10/13/2023

Gabapentin Oral Solution

Products Affected - Description

- Neurontin oral solution, Mylan (Viatris), 250 mg/5 mL, 470 mL bottle, NDC 00071-2012-47

Reason for the Shortage

- Acella has gabapentin oral solution available.
- Amneal has gabapentin oral solution available.
- Mylan did not provide a reason for the shortage.
- Gabapentin capsules are not affected by this shortage.

Available Products

- Gabapentin oral solution, Acella, 250 mg/5 mL, 470 mL bottle, NDC 42192-0608-16
- Gabapentin oral solution, Acella, 250 mg/5 mL, 5 mL cup, 40 count, NDC 42192-0608-45
- Gabapentin oral solution, Acella, 300 mg/6 mL, 6 mL cup, 40 count, NDC 42192-0608-40
- Gabapentin oral solution, Amneal, 250 mg/5 mL, 473 mL bottle, NDC 65162-0698-90
- Gabapentin oral solution, Mylan (Viatris), 250 mg/5 mL, 470 mL bottle, NDC 59762-5050-07

Estimated Resupply Dates

- Mylan has Neurontin 250 mg/5 mL oral solution in 470 mL bottles on back order and the company estimates a release date in mid-November 2023.

Updated

Updated October 13, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 1, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.